{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:15:47Z","timestamp":1760577347687},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1007\/bf03348199","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T17:08:06Z","timestamp":1397322486000},"page":"1001-1007","source":"Crossref","is-referenced-by-count":7,"title":["Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency"],"prefix":"10.1007","volume":"26","author":[{"given":"N.","family":"\u00d6zbey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Telci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Cakatay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yurci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Molvalilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"BF03348199_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Rosen","year":"1990","unstructured":"Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990, 336: 285\u20138.","journal-title":"Lancet"},{"key":"BF03348199_CR2","first-page":"1169","volume":"81","author":"AS Bates","year":"1996","unstructured":"Bates AS, Hoff WV, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996, 81: 1169\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03348199_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","volume":"46","author":"B B\u00fclow","year":"1997","unstructured":"B\u00fclow B, Hagmar L, Mikoczy Z, Nordstr\u00f6m C-H, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997, 46: 75\u201381.","journal-title":"Clin Endocrinol"},{"key":"BF03348199_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, et al. and the West Midlands Prospective Hypopituitary Study Group 2001. Association between premature mortality and hypopituitarism. Lancet 2001, 357: 425\u201331.","journal-title":"Lancet"},{"key":"BF03348199_CR5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0889-8529(05)70201-2","volume":"30","author":"S Stavrou","year":"2001","unstructured":"Stavrou S, Kleinberg DL. Diagnosis and management of GH deficiency in adults. Endocrinol Metab Clin North Am 2001, 30: 545\u201363.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF03348199_CR6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","volume":"340","author":"V Markussis","year":"1992","unstructured":"Markussis V, Besyah SA, Fischer C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high resolution ultrasonography in symptom free hypopituitary adults. Lancet 1992, 340: 1188\u201392.","journal-title":"Lancet"},{"key":"BF03348199_CR7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1210\/jcem.82.5.3951","volume":"82","author":"B Capaldo","year":"1997","unstructured":"Capaldo B, Patti L, Pliviero U, et al. Increased arterial intima media thickness in childhood onset growth hormone deficiency. J Clin Endocrinol Metab 1997, 82: 1373\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03348199_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/eje.0.1360157","volume":"136","author":"V Markussis","year":"1997","unstructured":"Markussis V, Beshyah SA, Fischer C, Parker K, Nicolaides AN, Johnston DG. Abnormal carotid artery wall dynamics in symptom free hypopituitary adults. Eur J Endocrinol 1997, 136: 157\u201364.","journal-title":"Eur J Endocrinol"},{"key":"BF03348199_CR9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1530\/eje.0.1420254","volume":"142","author":"LM Evans","year":"2000","unstructured":"Evans LM, Davies JS, Anderson RA, et al. The effect of GH replacement therapy on endothelial function and oxida-tive stress in adult growth hormone deficiency. Eur J Endocrinol 2000, 142: 254\u201362.","journal-title":"Eur J Endocrinol"},{"key":"BF03348199_CR10","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jcem.86.12.8087","volume":"86","author":"G Sesmilo","year":"2001","unstructured":"Sesmilo G, Miller KK, Hayden D, Klibanski A. Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab 2001, 86: 5774\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03348199_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","volume":"83","author":"PV Carroll","year":"1998","unstructured":"Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998, 83: 382\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03348199_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1999.00682.x","volume":"50","author":"SA Besyah","year":"1999","unstructured":"Besyah SA, Johnston DG. Cardiovascular disease risk and risk factors in adults with hypopituitarism. Clin Endocrinol (Oxf) 1999, 50: 1\u201315.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03348199_CR13","first-page":"125","volume":"129","author":"T Rosen","year":"1993","unstructured":"Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993, 129: 125\u2013200.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF03348199_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.2000.tb06187.x","volume":"899","author":"ER Stadtman","year":"2000","unstructured":"Stadtman ER, Levine RL. Protein oxidation. Ann NY Acad Sci 2000, 899: 191\u20138.","journal-title":"Ann NY Acad Sci"},{"key":"BF03348199_CR15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0891-5849(01)00717-1","volume":"31","author":"LJ Hazell","year":"2000","unstructured":"Hazell LJ, Baernthale G, Stocker R. Correlation between intima-to-media ratio, apoprotein B-100, myeloperoxidase and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic Biol Med 2000, 31: 1254\u201362.","journal-title":"Free Radic Biol Med"},{"key":"BF03348199_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3240001","volume":"324","author":"RT Dean","year":"1997","unstructured":"Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997, 324: 1\u201318.","journal-title":"Biochem J"},{"key":"BF03348199_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-001-8002-7","volume":"1","author":"SS Signorelli","year":"2001","unstructured":"Signorelli SS, Neri S, Di Pino L, et al. Oxidative stress and endothelial damage in patients with asymptomatic carotid atherosclerosis. Clin Exp Med 2001, 1: 9\u201312.","journal-title":"Clin Exp Med"},{"key":"BF03348199_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994, 233: 357\u201363.","journal-title":"Methods Enzymol"},{"key":"BF03348199_CR19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/bj3330519","volume":"333","author":"FU Shanlin","year":"1998","unstructured":"Shanlin FU, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 1998, 333: 519\u201325.","journal-title":"Biochem J"},{"key":"BF03348199_CR20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.2337\/diacare.21.10.1736","volume":"21","author":"C Dominguez","year":"1998","unstructured":"Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21: 1736\u201342, 1998.","journal-title":"Diabetes Care"},{"key":"BF03348199_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-2007-978584","volume":"32","author":"A Telci","year":"2000","unstructured":"Telci A, \u00c7akatay U, Kayah R, et al. Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 2000, 32: 40\u20133.","journal-title":"Horm Metab Res"},{"key":"BF03348199_CR22","first-page":"381","volume":"233","author":"ML Hu","year":"1994","unstructured":"Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994, 233: 381\u20135.","journal-title":"Methods Enzymol"},{"key":"BF03348199_CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1096\/fasebj.13.2.233","volume":"13","author":"E Bourdon","year":"1999","unstructured":"Bourdon E, Loreau D, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999, 13: 233\u201344.","journal-title":"FASEB J"},{"key":"BF03348199_CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-5793(95)00307-U","volume":"364","author":"H Ischiropoulos","year":"1995","unstructured":"Ischiropoulos H, Al-Mehdi AB. Peroxynitrite-mediated oxidative protein modification. FEBS Lett 1995, 364: 279\u201382.","journal-title":"FEBS Lett"},{"key":"BF03348199_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-5793(96)00347-X","volume":"385","author":"AJ Gow","year":"1996","unstructured":"Gow AJ, Duran D, Malcolm S, Ischiropoulos H. Effects of per-oxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996, 385: 63\u20136.","journal-title":"FEBS Lett"},{"key":"BF03348199_CR26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0891-5849(98)00184-1","volume":"25","author":"JCA Ter Steege","year":"1998","unstructured":"Ter Steege JCA, Koster-Kamphuis L, Van Straaten EA, Forget PP, Buurman WA. Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med 1998, 25: 953\u201363.","journal-title":"Free Radic Biol Med"},{"key":"BF03348199_CR27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0891-5849(95)00075-9","volume":"19","author":"S Salman-Tabcheh","year":"1995","unstructured":"Salman-Tabcheh S, Guerin MC, Tirreilles J. Nitration of tyrosyl-residues from extra- and intracellular proteins in human whole blood. Free Radic Biol Med 1995, 19: 695\u20138.","journal-title":"Free Radic Biol Med"},{"key":"BF03348199_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis \u2014 an inflammatory disease. N Engl J Med 1999, 340: 115\u201326.","journal-title":"N Engl J Med"},{"key":"BF03348199_CR29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","volume":"98","author":"P Holvoet","year":"1998","unstructured":"Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998, 98: 1487\u201394.","journal-title":"Circulation"},{"key":"BF03348199_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.ATV.18.1.100","volume":"18","author":"P Holvoet","year":"1998","unstructured":"Holvoet P, Stassen J-M, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998, 18: 100\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03348199_CR31","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.ATV.20.3.698","volume":"20","author":"P Holvoet","year":"2000","unstructured":"Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000, 20: 698\u2013702.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03348199_CR32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.ATV.21.5.844","volume":"21","author":"P Holvoet","year":"2001","unstructured":"Holvoet P, Mertens A, Verhamme P, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001, 21: 844\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03348199_CR33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2337\/diab.44.9.1054","volume":"44","author":"J Nourooz-Zadeh","year":"1995","unstructured":"Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995, 44: 1054\u20138.","journal-title":"Diabetes"},{"key":"BF03348199_CR34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","volume":"87","author":"ML Hartman","year":"2002","unstructured":"Hartman ML, Crowe BJ, Biller BMK, Ho KKY, Clemmons DR, Chipman JJ. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002, 87: 477\u201385.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03348199_CR35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2265.2002.01472.x","volume":"56","author":"JM Gomez","year":"2002","unstructured":"Gomez JM, Espadero RM, Escobar-Jimenez F, et al. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol (Oxf) 2002, 56: 329\u201334.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03348199_CR36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0076-6879(99)00113-5","volume":"300","author":"J Nourooz-Zadeh","year":"1999","unstructured":"Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999, 300: 58\u201362.","journal-title":"Methods Enzymol"},{"key":"BF03348199_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2265.2002.01493.x","volume":"56","author":"JC Smith","year":"2002","unstructured":"Smith JC, Lang D, McEneny J, et al. Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency. Clin Endocrinol (Oxf) 2002, 56: 449\u201355.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03348199_CR38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","volume":"56","author":"JC Smith","year":"2002","unstructured":"Smith JC, Evans LM, Wilkinson I, et al. Effects of GH replacement on endothelial function and large artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf) 2002, 56: 493\u2013501.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03348199_CR39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1507\/endocrj.48.579","volume":"48","author":"N Ozbey","year":"2001","unstructured":"Ozbey N, Aydin A, Telci A, Cakatay U. Antibodies against oxidised low density lipoprotein in hypopituitary patients with growth hormone deficiency. Endocr J 2001, 48: 579\u201384.","journal-title":"Endocr J"},{"key":"BF03348199_CR40","first-page":"453","volume":"84","author":"M Pfeifer","year":"1999","unstructured":"Pfeifer M, Verhovec R, Zizec B, Prezelj J, Poredos P, Clayton RN. Growth hormone treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 1999, 84: 453\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03348199_CR41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF03044353","volume":"22","author":"T Munzel","year":"1997","unstructured":"Munzel T, Heitzer T, Harrison DG. The physiology and pathophysiology of the nitricoxide\/superoxide system. Herz 1997, 22: 58\u2013172.","journal-title":"Herz"},{"key":"BF03348199_CR42","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","volume":"98","author":"RH B\u00f6ger","year":"1996","unstructured":"B\u00f6ger RH, Skamira C, Bode-B\u00f6ger SM, et al. Nitric oxide may mediate the haemodynamic effects of recombinant human growth hormone in patients with acquired growth hormone deficiency. J Clin Invest 1996, 98: 2706\u201313.","journal-title":"J Clin Invest"},{"key":"BF03348199_CR43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.1994.78","volume":"45","author":"H Tsukahara","year":"1994","unstructured":"Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor 1 induced nitric oxide production by endothelial cells. Kidney Int 1994, 45: 598\u2013604.","journal-title":"Kidney Int"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348199\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T13:07:57Z","timestamp":1565356077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["BF03348199"],"URL":"https:\/\/doi.org\/10.1007\/bf03348199","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}